Evidence map›Paper›PMID 40970925›Full record

ArticleAnnals of hematology2025

Primary effusion lymphoma with biphenotypic and bigenotypic features of T-cell receptor and IGH genes in an HIV-negative patient with kidney transplant.

Taesung Jeon, Young-Hyeh Ko, You-Na Sung, Hyunsung Kim, Ka-Won Kang, Jong-Min Sim, Yeseul Kim

Abstract readCase Reports
In one paragraph

Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Taesung JeonDepartment of Pathology, Korea University Guro Hospital, Seoul, Republic of Korea.
Young-Hyeh KoDepartment of Pathology, Cheju Halla General Hospital, Jeju, Republic of Korea.
You-Na SungDepartment of Pathology, Korea University Anam Hospital, Seoul, Republic of Korea.
Hyunsung KimDepartment of Pathology, Hanyang University College of Medicine, Seoul, Republic of Korea.
Ka-Won KangDivision of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Jong-Min SimDepartment of Pathology, Korea University Anam Hospital, Seoul, Republic of Korea.
Yeseul KimDepartment of Pathology, Korea University Anam Hospital, Seoul, Republic of Korea. yskimpath@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary effusion lymphoma (PEL) is a rare and aggressive non-Hodgkin lymphoma that primarily involves body cavities and is characterized by human herpes virus-8 (HHV-8) positivity and the presence of immunoblastic, plasmablastic or anaplastic cells. PEL typically lacks B-cell antigens, but involves immunoglobulin gene rearrangements, suggesting a B-cell origin. Here, we present a highly unusual case of PEL in which tumor cells expressed T-cell antigens but were also monoclonal for both T-cell receptor (TCR) and immunoglobulin heavy locus (IGH) gene rearrangements. An 81-year-old man with bilateral pleural effusions presented with atypical lymphoid cells. Immunohistochemistry revealed positivity for CD3, CD4, MUM-1, OCT2, BOB1, and HHV-8, but negativity for other T- and B-cell antigens. In situ hybridization identified Epstein-Barr virus and lambda light chain restriction. Gene rearrangement studies demonstrated monoclonal TRB (T-cell receptor beta locus) and TRG (T-cell receptor gamma locus) as well as IGH rearrangement. This unusual case of PEL with T-cell antigen expression and clonal rearrangement of both the TCR and IGH genes highlights the lineage complexity of this tumor.

Indexed as

HIV SeronegativityImmunoglobulin Heavy ChainsKidney TransplantationLymphoma, Primary EffusionReceptors, Antigen, T-CellAged, 80 and overHumansMaleImmunoglobulin Heavy ChainsReceptors, Antigen, T-CellBigenotypicBiphenotypicEBV-positiveHIV-negativeLineage infidelityPrimary effusion lymphoma

Identifiers

PMID40970925
PMCPMC12619830

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.